Granules India recalls over 2.3 cr ranitidine tablets from US market


PTI, Jan 12, 2020, 3:08 PM IST

New Delhi: Drug firm Granules India is recalling over 2.3 crore ranitidine tablets, used to treat ulcers of the stomach and intestines, from the US market, the latest report of the American health regulator said.

According to the Enforcement Report of the United States Food and Drug Administration (USFDA), the company is recalling 23,090,000 Ranitidine tablets USP 150mg, 10,000 count bag on account of “CGMP deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.”

CGMP refers to the Current Good Manufacturing Practice regulations.

The voluntary ongoing recall is a class II recall, it added.

As per the USFDA, a class II recall is initiated in a “situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

The tablets were distributed in Oregon, New York and New Jersey, the report said.

NDMA is classified as a probable human carcinogen (a substance that could cause cancer). It is a known environmental contaminant typically found in water and foods, including meats, dairy products and vegetables.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Dr. Vishnuvardhan memorial to be opened by December 2022: CM Bommai

General Mirza takes charge as Pakistan’s new CJCSC

Thirthahalli: CM Bommai sanctions Rs. 618 cr towards development projects

Protests against COVID lockdowns intensify in China; Protestors shout anti-Xi Jinping slogans

Bengaluru-Howrah Express train catches fire, no casualties reported

Narendra Modi Stadium gets Guinness record for highest T20 attendance: BCCI

Siddaramullah Khan will finish Hindus if brought to power: C T Ravi slams Siddaramaiah


Related Articles More

CII urges RBI to moderate pace of interest rates hikes

Macro data, global trends to guide markets this week: Analysts

STPI centre opened in Davanagere

Benchmark indices settle at fresh lifetime highs

SEBI amends norms! Buying, selling of mutual funds now comes under insider trading rules

MUST WATCH

Deepotsava at Shri Durga Adishakti temple

Girija Surgicals nebulizer vedio

KL Rahul Visit Kukke Subrahmanya Temple

Police commissioner N.Shahsikumar statement about viral video

CCTV Footage about mangaluru incident


Latest Additions

Dr. Vishnuvardhan memorial to be opened by December 2022: CM Bommai

General Mirza takes charge as Pakistan’s new CJCSC

Thirthahalli: CM Bommai sanctions Rs. 618 cr towards development projects

Protests against COVID lockdowns intensify in China; Protestors shout anti-Xi Jinping slogans

Bengaluru-Howrah Express train catches fire, no casualties reported

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.